|

PF-08046054/SGN-PDL1V Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Pfizer1

Indications

  • Advanced/Metastatic Non-Small Cell Lung Cancer1
  • Carcinoma, Non-Small-Cell Lung1
  • Lung Cancer1
  • Non Small Cell Lung Cancer1
  • Cancer1

Fayetteville, Arkansas1 trial

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Highlands Oncology Group, PA

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.